მადლობა ალისა!
From: Alisa Tsuladze
Sent: 25 May, 2020 14:01
To: Tamar Gabunia
Cc: Anzor tchavtchavadze
Subject: Re: ***New WHO Interim Guidance on COVID-19 Clinical Management***
გამარჯობა, ქალბატონო თამარ,
აკაკის ველაპარაკე დღეს და გაირკვა, რომ გაგზავნილი ჰქონიათ კლინიკური ჯგუფის სხვა წევრებისთვის გადასახედად ახალი ვერსია და გამომიგზავნის მეც;
ჩვენ შევადარებთ, რა თქმა უნდა რა არის განსხვავებული და ახალი.
პატივისცემით,
ალისა წულაძე
Best regards,
Alisa Tsuladze
ჯანმრთელობის დაცვის პოლიტიკის სამმართველო
პოლიტიკის დეპარტამენტი
საქართველოს ოკუპირებული ტერიტორიებიდან დევნილთა,
შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო
+995-32-2-51-00-26 ext 1125
Health Policy Division
Policy Department
Ministry of Internally Displaced persons from
Occupied Territories, Labor, Health and Social Affairs of Georgia
From: Tamar Gabunia
Sent: Monday, May 25, 2020 8:36 AM
To: Ekaterine Adamia
Cc: Anzor tchavtchavadze; Alisa Tsuladze
Subject: RE: ***New WHO Interim Guidance on COVID-19 Clinical Management***
ალისა
გთხოვ გადახედო ჯანმოს ახალ გაიდლაინს, ამოკრიბო განსახვავებული დებულებები და დავიწყოთ მუშაობა ჩვენი გაიდლაინის განახლებაზე. ‘
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia, MD, MPH
First Deputy Minister
From: MAMULASHVILI, Nino [mailto:mamulashvilin@who.int]
Sent: 22 May, 2020 19:15
To: Ekaterine Adamia <eadamia@moh.gov.ge>
Cc: Tamar Gabunia <tgabunia@moh.gov.ge>; DOMENTE, Silviu <domentes@who.int>; 'tt@aidscenter.ge' <tt@aidscenter.ge>; Anzor tchavtchavadze <atchavtchavadze@moh.gov.ge>; Alisa Tsuladze <atsuladze@moh.gov.ge>
Subject: FW: ***New WHO Interim Guidance on COVID-19 Clinical Management***
Importance: High
Dear Eka,
Hopefully you have received a new WHO Interim Guidance on COVID-19 Clinical Management.
Kind regards,
Nino
From: LYDON, Patrick
Sent: Thursday, May 21, 2020 22:49
To: solidaritytrials <solidaritytrials@who.int>
Cc: SWAMINATHAN, Soumya <swaminathans@who.int>; HENAO RESTREPO, Ana Maria <henaorestrepoa@who.int>; PREZIOSI, Marie-pierre <preziosim@who.int>; SATHIYAMOORTHY, Vaseeharan <moorthyv@who.int>; DARA, Masoud <daram@who.int>; OKEIBUNOR, Joseph Chukwudi <okeibunorj@who.int>; Reveiz, Dr. Ludovic (WDC) <reveizl@paho.org>; Maria Consuelo <mcmirandamontoya@hotmail.com>; KODAMA, Chiori <kodamac@who.int>; AZIM, Tasnim <azimt@who.int>; ESCALANTE, Socorro <escalantes@who.int>
Subject: ***New WHO Interim Guidance on COVID-19 Clinical Management***
Importance: High
Dear Solidarity Trial P.Is and esteemed colleagues,
We are pleased to be sharing with you the new WHO ‘interim’ guidance on COVID-19 clinical management (attached). This is a key documents in our collective objective to: (1) Slow and stop transmission of the virus; (2) Provide optimized care for all patients; and (3) Minimize the impact of the epidemic on health systems, social services and economic activity.
This guidance is intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. As all of you copied are involved in the Solidarity Trial, we wanted to make sure you get this document and we encourage you to share this broadly within your networks. Please note that it is not meant to replace clinical judgment or specialist consultation, but rather to strengthen frontline clinical management based on the latest WHO guidance.
Furthermore, we wanted to thank you for all your hard work, dedication and time with enrolling patients in Solidarity Trial. To date, 17 countries have started Solidarity Trial in 320 hospitals around the world and where 885 clinicians including yourselves are involved. Patient enrollment has surpassed 3,000 on May 18th – 8 weeks since the launch of the initiative on March 18 by the Director General of the WHO (Dr. Tedros). By the end of May, we expect another 10-12 countries to start enrolling patients with at least one country representing each WHO region. This is tremendous progress and we owe it to you. You should all be proud to be part of this global mega-trial to help research into an effective COVID-19 treatment and your efforts are not going unnoticed.
Of course, the battle against this pandemic is far from over and time is not on our side. The faster we can go, the quicker we can identify solutions. The international community is counting on your help to implement and accelerate all possible efforts for Solidarity Trial and to enroll as many patients as possible.
All the very best and keep safe.
Patrick
(on behalf of Dr Soumya (WHO Chief Scientist); the co-leads of Solidarity Trial (Dr Ana Maria, Dr Marie-Pierre and Dr Vasee); and our Regional and Country Office Focal points that have done an incredible job helping)
___________________________________________________________________________
Patrick Lydon
Research & Development Blueprint Unit – WHO Health Emergencies Preparedness & Response
World Health Organization | 20 Avenue Appia | CH-1211 Geneva 27 Switzerland | Office: M1156
*: lydonp@who.int |(:office +41.22.791.4238 |(:mobile +41.79.475.5550 |(:skype: patricklydon
Promote health, keep the world safe, and serve the vulnerable